s-triazine-based Derivatives as Anticancer Agents.
An overview of the recent primary literature concerning the development of s-triazine-based antitumor agents is provided, focusing on the most potent compounds acting on specific molecular targets and discussing the structure-activity relationships (SARs), when available.